DK3452040T3 - Formuleringer og behandlinger, der anvender hydroxypyridonataktinid/lanthanid-dekorporeringsmidler - Google Patents
Formuleringer og behandlinger, der anvender hydroxypyridonataktinid/lanthanid-dekorporeringsmidler Download PDFInfo
- Publication number
- DK3452040T3 DK3452040T3 DK17793154.0T DK17793154T DK3452040T3 DK 3452040 T3 DK3452040 T3 DK 3452040T3 DK 17793154 T DK17793154 T DK 17793154T DK 3452040 T3 DK3452040 T3 DK 3452040T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydroxypyridonate
- decorporating
- actinide
- lanthanide
- treatments
- Prior art date
Links
- 229910052768 actinide Inorganic materials 0.000 title 1
- 150000001255 actinides Chemical class 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 229910052747 lanthanoid Inorganic materials 0.000 title 1
- 150000002602 lanthanoids Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662331369P | 2016-05-03 | 2016-05-03 | |
US201662383963P | 2016-09-06 | 2016-09-06 | |
PCT/US2017/030628 WO2017192581A1 (en) | 2016-05-03 | 2017-05-02 | Formulations and treatments employing hydroxypyridonate actinide/lanthanide decorporation agents |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3452040T3 true DK3452040T3 (da) | 2024-05-21 |
Family
ID=60203422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK17793154.0T DK3452040T3 (da) | 2016-05-03 | 2017-05-02 | Formuleringer og behandlinger, der anvender hydroxypyridonataktinid/lanthanid-dekorporeringsmidler |
Country Status (6)
Country | Link |
---|---|
US (1) | US20190183868A1 (da) |
EP (2) | EP3452040B1 (da) |
JP (2) | JP2019514944A (da) |
CA (1) | CA3022852A1 (da) |
DK (1) | DK3452040T3 (da) |
WO (1) | WO2017192581A1 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10982136B2 (en) | 2016-02-26 | 2021-04-20 | The Regents Of The University Of California | Ligand-sensitized lanthanide nanocrystals as ultraviolet downconverters |
US11235076B2 (en) | 2016-08-29 | 2022-02-01 | Fred Hutchinson Cancer Research Center | Chelating platform for delivery of radionuclides |
CA3035966A1 (en) | 2016-09-06 | 2018-03-15 | The Regents Of The University Of California | Formulations of hydroxypyridonate actinide/lanthanide decorporation agents |
EP3520117B1 (en) | 2016-09-29 | 2023-11-08 | The Regents of The University of California | Separation of metal ions by liquid-liquid extraction |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6846915B2 (en) * | 2001-08-13 | 2005-01-25 | The Regents Of The University Of California | Hydroxypyridonate and hydroxypyrimidinone chelating agents |
US8217173B2 (en) * | 2007-02-13 | 2012-07-10 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Fluoride-releasing compositions |
US20110250138A1 (en) * | 2007-08-01 | 2011-10-13 | Alnylam Pharmaceuticals, Inc. | Single-stranded and double-stranded oligonucleotides comprising a metal-chelating ligand |
WO2010129962A2 (en) * | 2009-05-08 | 2010-11-11 | The Regents Of The University Of California | Combination treatment of hydroxypyridonate actinide/lanthanide decorporation agents |
AU2014232416B2 (en) * | 2013-03-15 | 2017-09-28 | Xencor, Inc. | Modulation of T Cells with Bispecific Antibodies and FC Fusions |
-
2017
- 2017-05-02 WO PCT/US2017/030628 patent/WO2017192581A1/en unknown
- 2017-05-02 EP EP17793154.0A patent/EP3452040B1/en active Active
- 2017-05-02 US US16/097,782 patent/US20190183868A1/en active Pending
- 2017-05-02 CA CA3022852A patent/CA3022852A1/en active Pending
- 2017-05-02 JP JP2018557384A patent/JP2019514944A/ja not_active Withdrawn
- 2017-05-02 DK DK17793154.0T patent/DK3452040T3/da active
- 2017-05-02 EP EP24168102.2A patent/EP4393548A2/en active Pending
-
2023
- 2023-02-06 JP JP2023016016A patent/JP2023041952A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20190183868A1 (en) | 2019-06-20 |
EP3452040B1 (en) | 2024-04-03 |
EP3452040A4 (en) | 2019-12-25 |
JP2019514944A (ja) | 2019-06-06 |
JP2023041952A (ja) | 2023-03-24 |
EP4393548A2 (en) | 2024-07-03 |
WO2017192581A1 (en) | 2017-11-09 |
EP3452040A1 (en) | 2019-03-13 |
CA3022852A1 (en) | 2017-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3411398T3 (da) | Målrettede terapeutiske midler og anvendelse heraf | |
DK3142637T3 (da) | Keratin treatment formulations and methods | |
DK3557998T3 (da) | Sammensætninger, kompositioner og anvendelsesmetoder | |
DK3505519T3 (da) | Pyridinamin-substituerede heterotricyclo-forbindelser, fremstilling deraf og anvendelse i medicin | |
DK3307707T3 (da) | Halogensubstituerede phenoxyphenylamidiner og anvendelsen deraf som fungicider | |
DK3177640T3 (da) | Pd-1-midler med høj affinitet og anvendelsesfremgangsmåder | |
DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
DK3610005T3 (da) | Peptidligase og anvendelse deraf | |
DK3492455T3 (da) | 1,2,4-triazoler som nukleare transportmodulatorer og anvendelse til behandling af specifikke former for cancer | |
MA42844A (fr) | Combinaisons thérapeutiques comprenant des immunoconjugués anti-folr1 | |
DK3143011T3 (da) | Deutererede heterocykliske forbindelser og deres anvendelse som billeddannende stoffer | |
MA41794A (fr) | Agents thérapeutiques modifiés et compositions associées | |
DK3256598T3 (da) | Svampestammer og anvendelsesfremgangsmåder | |
DK3268374T3 (da) | Kv1.3-inhibitorer og deres medicinske anvendelse | |
DK3420039T3 (da) | Printningsformuleringer og fremgangsmåder | |
DK3558260T3 (da) | Kosmetisk sammensætning omfattende et chaga-ekstrakt og anvendelse deraf | |
DK3288825T3 (da) | Teleskopisk adgangsbro, enhed forsynet hermed og tilhørende fremgangsmåde | |
DK3452040T3 (da) | Formuleringer og behandlinger, der anvender hydroxypyridonataktinid/lanthanid-dekorporeringsmidler | |
DK3326463T3 (da) | Midesammensætning og anvendelse deraf som biologisk bekæmpelsesmiddel | |
DK3156181T3 (da) | Sikkerhedsindretning og værktøj | |
FR3020946B1 (fr) | Nouvelles preparations cosmetiques et/ou dermatologiques extemporanees | |
DK3490988T3 (da) | Ny forbindelse og fremgangsmåde | |
DK3491345T3 (da) | Pumpehoved og doseringsenhed | |
DK3383872T3 (da) | 1,3,4-thiadiazolforbindelser og anvendelse deraf i cancerbehandling | |
DK3383397T3 (da) | Farmaceutiske sammensætninger indeholdende doravirin, tenofovirdisoproxilfumarat og lamivudin |